Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Chinese Journal of Cardiology ; (12): 814-818, 2010.
Article in Chinese | WPRIM | ID: wpr-244139

ABSTRACT

<p><b>OBJECTIVE</b>to investigate the combined effect of rosuvastatin (RSV) and ischemic postconditioning (PC) on myocardial ischemia-reperfusion (I/R) injury in a type 2 diabetic rat model.</p><p><b>METHODS</b>type 2 diabetic (induced by streptozotocin plus nicotinamide) rats, undergoing 30 min ischemia and 120 min reperfusion, were divided into six groups (n = 10 each): Sham, I/R without other interventions, RSV before reperfusion, PC with 3 cycles of 10 s reperfusion and 10 s ischemia, RSV + PC and RSV + PC + PI3-K inhibitor LY294002. Myocardial infarct size (IS), ultrastructural change and myocardial expression of phosphorylated eNOS/total eNOS were determined.</p><p><b>RESULTS</b>IS and ultrastructural damages were all significantly reduced and myocardial eNOS phosphorylation was significantly increased in RSV and PC groups compared with the I/R group (all P < 0.05) these beneficial effects were further enhanced by RSV + PC (all P < 0.05 vs. RSV and PC, respectively). The beneficial effects were significantly attenuated by PI3K inhibitor LY294002.</p><p><b>CONCLUSIONS</b>the results indicate that RSV + PC could alleviate myocardial ischemia-reperfusion injury in this type 2 diabetic model by activating PI3K/AKT/eNOS signaling pathway.</p>


Subject(s)
Animals , Male , Rats , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Fluorobenzenes , Pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors , Pharmacology , Ischemic Postconditioning , Myocardial Reperfusion Injury , Myocardium , Pathology , Nitric Oxide Synthase Type III , Metabolism , Phosphatidylinositol 3-Kinases , Metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt , Metabolism , Pyrimidines , Pharmacology , Rats, Wistar , Rosuvastatin Calcium , Signal Transduction , Sulfonamides , Pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL